Elevance Health (ELV) Short-term Investments (2009 - 2026)

Elevance Health (ELV) has 18 years of Short-term Investments data on file, last reported at $25.7 billion in Q2 2026.

• On a quarterly basis, Short-term Investments rose 2653.64% year-over-year to $25.7 billion in Q2 2026; TTM through Jun 2026 was $25.7 billion, a 2653.64% increase from a year earlier, with the FY2025 full-year figure at $740.0 million, down 37.92% from the prior year.
• Short-term Investments for Q2 2026 stood at $25.7 billion, down from $25.9 billion in the prior quarter.
• Over the last five years, Short-term Investments for ELV reached as high as $26.3 billion in Q3 2025 and fell as low as $165.0 million in Q3 2023.
• Historically, Short-term Investments has averaged $5.0 billion across 5 years, with a median of $943.5 million in 2022.
• Across the five-year window, Short-term Investments slumped 96.37% in 2022 and soared 3523.08% in 2026, its largest moves.
• Year by year, Short-term Investments stood at $953.0 million in 2022, then tumbled by 75.97% to $229.0 million in 2023, then surged by 420.52% to $1.2 billion in 2024, then tumbled by 37.92% to $740.0 million in 2025, then jumped by 3375.54% to $25.7 billion in 2026.
• Per Business Quant data, the three most recent Short-term Investments figures were $25.7 billion in Q2 2026, $25.9 billion in Q1 2026, and $740.0 million in Q4 2025.